RSS feeds in the directory: 2794
Added today: 0
Added yesterday: 0
The Fifth special investment contract was signed on March 7, the Ministry of industry and trade of Russia, administration of Kaluga region and the company Novamedica (a portfolio company of RUSNANO).
the Signature under the document was signed by Minister of industry and trade Denis Manturov, the Governor of Kaluga region Anatoly Artamonov and the General Director of "developing novamedica's" Alexander Kuzin.
under the agreement, in the Kaluga region will be created "from scratch" modern pharmaceutical plant for the production of 24 sterile injectable drugs related to vital. Among them: drugs for treatment of oncological diseases, including in children for General anesthesia, hemostatic and anti-inflammatory drugs, as well as for the treatment of serious bacterial and fungal infections.
These molecules were transferred to the company in the process of localization in Russia of production of Pfizer. About a third of them are currently not produced in Russia.
the ceremony was also attended by Deputy Prime Minister Arkady Dvorkovich and Chairman of the Board of UK "RUSNANO" Anatoly Chubais.
the Modern pharmaceutical complex Novamedica will be built in Vorsino industrial Park. In addition to localized here will produce drugs developed through own R&D program "developing novamedica".
the Plant will be established in accordance with international and Russian quality standards, including the European rules of good manufacturing practice (GMP EU). In the future it will allow the company to export about 20% of its production to international markets, which is one of the terms of this Spica. In the framework of the investment project, the company invests at least 3 billion roubles and create about 300 high-tech jobs.
"implementation of the investment project will significantly increase access for Russian patients modern, effective and safe drugs, most of which are included in the list of vital and essential medicines, the prices of which are regulated by the government", – concluded Denis Manturov.
"SPIK "Novamedica" is the second in the framework of the Kaluga pharmaceutical cluster. It is important that it reflects well on the localization of innovation in the region will increase production of marketable products, tax deductions, and will also allow the creation of new, including high-tech jobs," said Anatoly Artamonov.
All drugs manufactured by companies in the framework of Spica, is designed for the hospital sector and will participate in public procurement, said, "PV" Alexander Kuzin.
the Government guarantee of the company under the agreement, the tax benefits, the immutability of the conditions and status of local manufacturer. As assured, Arkady Dvorkovich, the state guarantees the company's political support and continuity conditions.
According to the Ministry of industry and trade of the Russian Federation, in the framework of specinvtehnica given Spika "developing novamedica" in the Russian pharmaceutical industry attracted more than 9.3 billion rubles of investments.
Women's day: Vladimir Putin seized parsania 08.03.2018 at 13:00
Became known to new General Director of "Pharmacy chain 36.6" 07.03.2018 at 13:00
"Akrikhin" localized production of antidiabetic drug MSD 06.03.2018 at 21:00
"Erkafarm" runs the direction of the drogher 06.03.2018 at 13:00
FAS clarifies the issues of formation of prices for medicines from the VED list 03.03.2018 at 21:00
Expert: clarification of procurement of drugs has not made clear 03.03.2018 at 13:00